Hans-jurgen J. Stellbrink
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial.
Journal: Pharmacological research
Published: February 27, 2025
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
Journal: The Journal of antimicrobial chemotherapy
Published: April 12, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 20, 2023
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
Journal: EClinicalMedicine
Published: February 10, 2023
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study.
Journal: JHEP reports : innovation in hepatology
Published: November 08, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 07, 2022
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
Journal: The New England journal of medicine
Published: May 11, 2022
Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes.
Journal: HIV research & clinical practice
Published: March 02, 2022
Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression.
Journal: Frontiers in immunology
Published: January 31, 2022
Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017.
Journal: Infection
Published: August 04, 2021
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe.
Journal: HIV medicine
Published: July 02, 2021
Last Updated: 09/26/2026